Enzo Biochem (ENZ)
0.6531 -0.0049 (-0.74%) 01/24/25 [NYSE]
0.6203 x 1,300 1.3000 x 100
Realtime by (Cboe BZX)
0.6203 x 1,300 1.3000 x 100
Realtime 0.6444 -0.0087 (-) 01/24/25
for Fri, Jan 24th, 2025
Fiscal Year End Date: 07/31
07-2019 | 07-2018 | 07-2017 | 07-2016 | 07-2015 | |
Cash Flows From Operating Activities | |||||
Net Income | 2,489 | -10,321 | -2,504 | 45,286 | -2,285 |
Depreciation Amortization | 3,036 | 3,130 | 3,598 | 3,840 | 3,789 |
Income taxes - deferred | N/A | N/A | N/A | -60 | -104 |
Accounts receivable | 2,404 | 1,915 | -469 | 1,859 | -8,653 |
Accounts payable and accrued liabilities | -2,508 | -887 | 515 | 1,103 | 394 |
Other Working Capital | -3,006 | 2,339 | -2,378 | 133 | -9,139 |
Other Operating Activity | 2,391 | 1,089 | 1,033 | 965 | 12,298 |
Operating Cash Flow | $4,806 | $-2,735 | $-205 | $53,126 | $-3,700 |
Cash Flows From Investing Activities | |||||
PPE Investments | -8,126 | -1,888 | -1,753 | -1,530 | -1,783 |
Other Investing Activity | 0 | -56 | 4 | 18 | 31 |
Investing Cash Flow | $-8,126 | $-1,944 | $-1,749 | $-1,512 | $-1,752 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | N/A | N/A | 89,880 | 88,632 |
Debt Issued | 4,500 | N/A | 40,694 | N/A | N/A |
Debt Repayment | -404 | -327 | -42,816 | -565 | -463 |
Common Stock Issued | 167 | 886 | 453 | 90 | 6,688 |
Other Financing Activity | -70 | 0 | 0 | -91,336 | -88,632 |
Financing Cash Flow | $4,193 | $559 | $-1,669 | $-1,931 | $6,225 |
Exchange Rate Effect | -18 | -6 | 13 | -15 | -119 |
Beginning Cash Position | 60,041 | 64,167 | 67,777 | 18,109 | 17,455 |
End Cash Position | 60,896 | 60,041 | 64,167 | 67,777 | 18,109 |
Net Cash Flow | $855 | $-4,126 | $-3,610 | $49,668 | $654 |
Free Cash Flow | |||||
Operating Cash Flow | 4,806 | -2,735 | -205 | 53,126 | -3,700 |
Capital Expenditure | -8,126 | -1,888 | -1,753 | -1,530 | -1,783 |
Free Cash Flow | -3,320 | -4,623 | -1,958 | 51,596 | -5,483 |